Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53

[1]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[2]  Andrew H. Beck,et al.  Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. , 2016, Cancer research.

[3]  R. Schiff,et al.  Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer. , 2015, Clinical breast cancer.

[4]  D. Edwards,et al.  Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer , 2015, Breast Cancer Research.

[5]  E. Cuyás,et al.  Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas , 2015, Oncotarget.

[6]  P. Spanheimer,et al.  A Novel Animal Model for Locally Advanced Breast Cancer , 2015, Annals of Surgical Oncology.

[7]  Shan Sun,et al.  Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain. , 2014, Cancer letters.

[8]  M. Kumar,et al.  Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis , 2014, Cancer Cell International.

[9]  W. Han,et al.  Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines. , 2013, International journal of oncology.

[10]  Jun Yao,et al.  Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. , 2013, Cancer cell.

[11]  Javier A Menendez,et al.  Basal/HER2 breast carcinomas , 2013, Cell cycle.

[12]  M. Houshmand,et al.  Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines , 2012, Cancer Cell International.

[13]  Yoko Takahashi,et al.  Establishment and Characterization of Novel Cell Lines from Sinonasal Undifferentiated Carcinoma , 2012, Clinical Cancer Research.

[14]  Dongling Yang,et al.  CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer , 2011, Proceedings of the National Academy of Sciences.

[15]  R. Hass,et al.  Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies , 2009, Journal of experimental & clinical cancer research : CR.

[16]  Meijia Gu,et al.  Cancer Cell International Establishment and Characterization of Three New Human Breast Cancer Cell Lines Derived from Chinese Breast Cancer Tissues , 2022 .

[17]  F. Meng,et al.  Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers. , 2008, Human pathology.

[18]  R. Ralhan,et al.  Establishment and characterisation of two novel breast cancer cell lines , 2008, Cell biology international.

[19]  C. Wongkham,et al.  Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma , 2007, Cancer.

[20]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[21]  M. Olivé,et al.  Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.

[22]  J. Yook,et al.  Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells , 2005, Experimental & Molecular Medicine.

[23]  C. Osborne,et al.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories , 2005, Breast Cancer Research and Treatment.

[24]  F. Lung,et al.  p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan , 2004, Journal of Cancer Research and Clinical Oncology.

[25]  J. Double,et al.  Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice , 1997, Breast Cancer Research and Treatment.

[26]  Valerie Speirs,et al.  Breast cancer cell lines: friend or foe? , 2003, Breast Cancer Research.

[27]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[28]  A. Green,et al.  A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples , 1996, International journal of cancer.

[29]  Robert Clarke,et al.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.

[30]  P. Meltzer,et al.  Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. , 1991, British Journal of Cancer.

[31]  M. Radu,et al.  Establishment and characterization of a cell line of human breast carcinoma origin. , 1979, European journal of cancer.

[32]  E. L. Springer,et al.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.

[33]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.